24/7 Market News- LSM Launching GeeWiz Sales
DENVER, Colo., Aug 14, 2024 (247marketnews.com)- Avalon GloboCare Corp. (NASDAQ: ALBT) stated that Laboratory Services MSO, which Avalon owns a 40% interest in, is now manufacturing the GeeWhiz External Condom Catheter, a patented, FDA-registered, in-market, male incontinence device, and plans to launch its sales in the third quarter of 2024.
Avalon GloboCare’s President and CEO, David Jin, M.D., Ph.D., commented, “We are thrilled to introduce the GeeWhiz External Condom Catheter to the market in the anticipated upcoming launch.
“The GeeWhiz External Condom Catheter represents a significant advancement in managing male incontinence. Not only is this device FDA-registered and approved for reimbursement by Medicare, but it is also supported by several private insurance providers.
“The GeeWhiz External Condom Catheter is meticulously engineered to address the needs of men with urinary incontinence and bladder control issues. Its innovative design aims to provide enhanced comfort, security, and ease of use, ultimately improving the quality of life for users. We are confident that this product will meet a critical need in the market and deliver substantial benefits to patients and healthcare providers alike. The anticipated upcoming launch of GeeWhiz underscores our commitment to advancing healthcare solutions and expanding our impact in the medical device industry.”
About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.
24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.
CONTACT:
24/7 Market News
Editor@247marketnews.com
Related news for (ALBT)
- Don’t Miss Out: MoBot’s Latest Stock Updates 07/28/25 10:00 AM
- Avalon GloboCare Enters into Distribution Agreement with Saga Health for KetoAir Targeting First Responders
- 24/7 Market News Snapshot 28 July, 2025 – Avalon GloboCare Corp. Common Stock (NASDAQ:ALBT)
- Avalon GloboCare Announces Patent Issuance for Novel CAR-T and CAR-NK Cell Technology in Hong Kong
- 24/7 Market News Snapshot 14 July, 2025 – Avalon GloboCare Corp. Common Stock (NASDAQ:ALBT)